RX Note

JUNE 21, 2023

Introduction HIV (Human immunodeficiency virus) is an enveloped, single-stranded RNA virus that was recognized as the causative agent of AIDS (acquired immune deficiency syndrome). 2 types of human HIV exist: HIV-1 and HIV-2. 2 types of human HIV exist: HIV-1 and HIV-2.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Immunity Immunization Hospitals 52

Pharmacy Times

JULY 8, 2025

Further research is needed on the clinical impact, treatment longevity, and cost implications of biosimilar use in pediatric IBD. These diseases are caused by a dysregulated mucosal immune response to the intestinal microflora in hosts who are genetically predisposed.

26

26

Pharmaceutical Technology

JUNE 11, 2025

The US Food and Drug Administration (FDA) has placed a clinical hold on several of Gilead’s trials evaluating two HIV treatment candidates, though the rest of the drugmaker’s diverse pipeline remains unaffected. Gilead is considered the leading big pharma in HIV treatments. Shares in Nasdaq-listed Gilead opened 0.3%

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Communication Hospitals Packaging 52

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.

Diabetes 32

Diabetes HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies 32

Pharmacy Times

JUNE 16, 2025

Although the use of colony-stimulating factors (CSFs) is well-established in mitigating severe FN, existing literature suggests there is only an approximate 3% difference in FN rates between various CSF agents. Utilizing colony-stimulating factors (CSFs) decreases the incidence of severe FN.

Inpatient 29

Inpatient HIV Treatment and Prevention Agents Pharmacy Technician Chemotherapy 29

Pharmacy Times

JUNE 10, 2025

The convenience of once-daily dosing and a rapid IV bolus administration may offer workflow efficiencies in hospital or surgical settings, where minimizing polypharmacy and streamlining medication administration are important goals. 2 REFERENCES 1.

Pharmacy Technician 29

Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies Biosimilars 29

Pharmacy Times

JULY 3, 2025

She emphasizes that treatment options are mostly supportive, making prevention through good hygiene and vaccination essential. Pharmacy Times: What are the key challenges in managing the high burden of RSV hospitalizations in older adults, and what broader strategies are needed to address them?

HIV Treatment and Prevention Agents 32

HIV Treatment and Prevention Agents Pharmacy Technician Hospitals Compounding Pharmacies 32